• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

源自人甲状腺肿瘤的四种细胞系在高剂量率或低剂量率下的特征及放射敏感性

Characterization and radiosensitivity at high or low dose rate of four cell lines derived from human thyroid tumors.

作者信息

Challeton C, Branea F, Schlumberger M, Gaillard N, de Vathaire F, Badie C, Antonini P, Parmentier C

机构信息

Service de Médecine Nucléaire, INSERM U 66, Institut Gustave Roussy, Villejuif, France.

出版信息

Int J Radiat Oncol Biol Phys. 1997 Jan 1;37(1):163-9. doi: 10.1016/s0360-3016(96)00449-x.

DOI:10.1016/s0360-3016(96)00449-x
PMID:9054892
Abstract

PURPOSE

This study attempted to establish cell lines derived from human differentiated thyroid tumors, and to characterize and evaluate the radiation dose-rate effect.

METHODS AND MATERIALS

Two cell lines (K1 and K2) were derived from papillary carcinomas, one (K7) from a follicular less-differentiated carcinoma and one (A14) from a follicular adenoma. Cell-survival curves after irradiation were established by the in vitro colony method. Radiation doses were delivered either at a high (45.9 Gy/h) or low dose rate (0.6 Gy/h) by a 60Co source. The data were analyzed according to the linear quadratic and multitarget model of radiation action.

RESULTS

Doubling times were around 24 h. All cell lines were positive for intracellular thyroglobulin. Cyclic adenosine monophosphate (cAMP) response to thyrotropin (TSH) was significant for the cell lines derived from the follicular adenoma and follicular carcinoma. The two cell lines derived from papillary carcinomas were tumorigenic after inoculation into nude mice. After high-dose-rate irradiation, the surviving fraction at 2 Gy (SF2) was not significantly different for the three malignant cell lines K1, K2, and K7, and ranged from 0.39 to 0.42. For the adenoma cell line A14, we found a higher radiosensitivity with a lower SF2 value and a higher alpha parameter. After low-dose-rate irradiation, only one cell line (K2) showed a significant low-dose-rate sparing with a dose reduction factor of 1.35.

CONCLUSION

The major result of our study is the weak effect of the dose rate on the survival of thyroid cell lines.

摘要

目的

本研究试图建立源自人分化型甲状腺肿瘤的细胞系,并对辐射剂量率效应进行表征和评估。

方法与材料

两个细胞系(K1和K2)源自乳头状癌,一个(K7)源自低分化滤泡状癌,一个(A14)源自滤泡性腺瘤。通过体外集落法建立照射后的细胞存活曲线。使用60Co源以高剂量率(45.9 Gy/h)或低剂量率(0.6 Gy/h)给予辐射剂量。根据辐射作用的线性二次模型和多靶模型对数据进行分析。

结果

倍增时间约为24小时。所有细胞系的细胞内甲状腺球蛋白均呈阳性。源自滤泡性腺瘤和滤泡状癌的细胞系对促甲状腺激素(TSH)的环磷酸腺苷(cAMP)反应显著。源自乳头状癌的两个细胞系接种到裸鼠后具有致瘤性。高剂量率照射后,三种恶性细胞系K1、K2和K7在2 Gy时的存活分数(SF2)无显著差异,范围为0.39至0.42。对于腺癌细胞系A14,我们发现其放射敏感性较高,SF2值较低且α参数较高。低剂量率照射后,只有一个细胞系(K2)表现出显著的低剂量率 sparing,剂量降低因子为1.35。

结论

我们研究的主要结果是剂量率对甲状腺细胞系存活的影响较弱。

相似文献

1
Characterization and radiosensitivity at high or low dose rate of four cell lines derived from human thyroid tumors.源自人甲状腺肿瘤的四种细胞系在高剂量率或低剂量率下的特征及放射敏感性
Int J Radiat Oncol Biol Phys. 1997 Jan 1;37(1):163-9. doi: 10.1016/s0360-3016(96)00449-x.
2
Immunohistochemical studies on thyroid peroxidase and thyroglobulin in 13 human thyroid tumors and 7 Graves' goiters.
Endocr J. 1993 Dec;40(6):683-90. doi: 10.1507/endocrj.40.683.
3
Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.高迁移率族蛋白I HMGI(Y)在甲状腺肿瘤诊断中的检测:HMGI(Y)表达是癌的一种潜在诊断指标。
Cancer Res. 1998 Sep 15;58(18):4193-8.
4
Immunohistochemistry of thyroid carcinoma--an experience with thyroglobulin and calcitonin.
Indian J Pathol Microbiol. 1998 Apr;41(2):163-7.
5
E-cadherin gene alterations are rare events in thyroid tumors.E-钙黏蛋白基因改变在甲状腺肿瘤中是罕见事件。
Int J Cancer. 1997 Jan 6;70(1):32-8. doi: 10.1002/(sici)1097-0215(19970106)70:1<32::aid-ijc5>3.0.co;2-7.
6
Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.放射免疫疗法与体外及体内人肾细胞癌异种移植瘤外照射放疗的放射生物学研究。
Cancer. 1997 Dec 15;80(12 Suppl):2519-28. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2519::aid-cncr26>3.3.co;2-t.
7
S-100 protein is a differentiation marker in thyroid carcinoma of follicular cell origin: an immunohistochemical study.S-100蛋白是滤泡细胞源性甲状腺癌的一种分化标志物:一项免疫组织化学研究。
Pathol Int. 1997 Oct;47(10):673-9. doi: 10.1111/j.1440-1827.1997.tb04440.x.
8
Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.Pax-8、p53和bcl-2在人类甲状腺良恶性疾病中的表达
Anticancer Res. 2000 Jan-Feb;20(1A):311-6.
9
Expression of fibroblast growth factors in thyroid cancer.成纤维细胞生长因子在甲状腺癌中的表达。
J Clin Endocrinol Metab. 1995 Mar;80(3):1006-11. doi: 10.1210/jcem.80.3.7533768.
10
Increased expression of CD44 variants in differentiated thyroid cancers.CD44变体在分化型甲状腺癌中的表达增加。
Jpn J Cancer Res. 1996 Dec;87(12):1245-50. doi: 10.1111/j.1349-7006.1996.tb03139.x.

引用本文的文献

1
The Use of Survival Dose-Rate Dependencies as Theoretical Discrimination Criteria for Dynamic Radiobiological Models.将存活剂量率依赖性用作动态放射生物学模型的理论判别标准
Dose Response. 2024 Aug 30;22(3):15593258241279906. doi: 10.1177/15593258241279906. eCollection 2024 Jul-Sep.
2
I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response.基于 I-124 PET/CT 图像的分化型甲状腺癌患者碘-131 治疗剂量学:患者特异性病灶剂量学与治疗反应的相关性。
Ann Nucl Med. 2022 Mar;36(3):213-223. doi: 10.1007/s12149-021-01655-y. Epub 2022 Feb 4.
3
FoxP3 promotes lymph node metastasis in patients with papillary thyroid carcinoma complicated with Hashimoto's thyroiditis.
FoxP3促进合并桥本甲状腺炎的甲状腺乳头状癌患者的淋巴结转移。
Transl Cancer Res. 2020 Mar;9(3):1337-1350. doi: 10.21037/tcr.2020.01.12.
4
Calcitriol enhances Doxorubicin-induced apoptosis in papillary thyroid carcinoma cells via regulating VDR/PTPN2/p-STAT3 pathway.骨化三醇通过调节 VDR/PTPN2/p-STAT3 通路增强多柔比星诱导的甲状腺乳头状癌细胞凋亡。
J Cell Mol Med. 2020 May;24(10):5629-5639. doi: 10.1111/jcmm.15224. Epub 2020 Apr 13.
5
Correction for hyperfunctioning radiation-induced stunning (CHRIS) in benign thyroid diseases.良性甲状腺疾病中针对功能亢进性辐射诱导性甲状腺功能减退(CHRIS)的纠正
Endocrine. 2020 Aug;69(2):466-473. doi: 10.1007/s12020-020-02258-9. Epub 2020 Mar 16.
6
MAPK- and AKT-activated thyroid cancers are sensitive to group I PAK inhibition.MAPK 和 AKT 激活的甲状腺癌对 I 组 PAK 抑制敏感。
Endocr Relat Cancer. 2019 Aug;26(8):699-712. doi: 10.1530/ERC-19-0188.
7
Positive effect of RORγt on the prognosis of thyroid papillary carcinoma patients combined with Hashimoto's thyroiditis.RORγt对合并桥本甲状腺炎的甲状腺乳头状癌患者预后的积极影响。
Am J Transl Res. 2018 Oct 15;10(10):3011-3024. eCollection 2018.
8
Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts.患者匹配甲状腺细胞系和患者来源肿瘤异种移植物的方法学、标准和特征描述。
J Clin Endocrinol Metab. 2018 Sep 1;103(9):3169-3182. doi: 10.1210/jc.2017-01845.
9
Extracellular ATP is Differentially Metabolized on Papillary Thyroid Carcinoma Cells Surface in Comparison to Normal Cells.与正常细胞相比,细胞外ATP在甲状腺乳头状癌细胞表面的代谢方式存在差异。
Cancer Microenviron. 2018 Jun;11(1):61-70. doi: 10.1007/s12307-018-0206-4. Epub 2018 Feb 17.
10
Radiolabeling of VEGF165 with 99mTc to evaluate VEGFR expression in tumor angiogenesis.用99mTc对血管内皮生长因子165(VEGF165)进行放射性标记以评估肿瘤血管生成中的血管内皮生长因子受体(VEGFR)表达。
Int J Oncol. 2017 Jun;50(6):2171-2179. doi: 10.3892/ijo.2017.3989. Epub 2017 May 8.